These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33637051)

  • 41. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium?
    Bielen R; Kremer C; Koc ÖM; Busschots D; Hendrickx DM; Vanelderen P; Hens N; Nevens F; Robaeys G
    Liver Int; 2019 Apr; 39(4):667-675. PubMed ID: 30525269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
    Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C prevalence--a nationwide serosurvey.
    Amin J; Gidding H; Gilbert G; Backhouse J; Kaldor J; Dore G; Burgess M
    Commun Dis Intell Q Rep; 2004; 28(4):517-21. PubMed ID: 15745402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
    Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
    Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.
    García Comas L; Ordobás Gavín M; Sanz Moreno JC; Ramos Blázquez B; Gutiérrez Rodríguez A; Astray Mochales J; Moreno Guillén S
    J Med Virol; 2015 Oct; 87(10):1697-701. PubMed ID: 25989026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral hepatitis C infection among Egyptians the magnitude of the problem: epidemiological and laboratory approach.
    Mohamed MK; Rakhaa M; Shoeir S; Saber M
    J Egypt Public Health Assoc; 1996; 71(1-2):79-111. PubMed ID: 17217003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A cross-sectional survey on hepatitis C virus infection among residents aged 18-59 years in a former commercial blood donating community, Shanxi Province].
    Shi XM; Mei ZQ; Gao JH; Qiao XC; Qian HZ; Jia WQ; Yang ZM; Zhang YL; Zheng XW; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):864-7. PubMed ID: 16676606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of hepatitis C prevalence in the Punjab province of Pakistan: A retrospective study on general population.
    Ahsan A; Khan AZ; Javed H; Mirza S; Chaudhary SU; Shahzad-Ul-Hussan S
    PLoS One; 2019; 14(4):e0214435. PubMed ID: 30943224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.
    Bruggmann P; Negro F; Bihl F; Blach S; Lavanchy D; Müllhaupt B; Razavi H; Semela D
    Swiss Med Wkly; 2015; 145():w14221. PubMed ID: 26715488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Estonia, July to December 2022.
    Hleyhel M; Geller J; Sadou A; Naaber P; Kuznetsova T; Vorobjov S; Lõhmus M; Furegato M; Reed S; Bluemel B; Duffell E; Rüütel K
    Euro Surveill; 2024 Jul; 29(30):. PubMed ID: 39056201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics.
    Özer B; Seydaoğlu G; Özşahın AK; Demırhındı H
    Turk J Gastroenterol; 2012; 23(5):574-9. PubMed ID: 23161304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo.
    Laurent C; Henzel D; Mulanga-Kabeya C; Maertens G; Larouzé B; Delaporte E
    Int J Epidemiol; 2001 Aug; 30(4):872-7. PubMed ID: 11511619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.
    Freiman JM; Wang J; Easterbrook PJ; Horsburgh CR; Marinucci F; White LF; Kamkamidze G; Krajden M; Loarec A; Njouom R; Nguyen KV; Shiha G; Soliman R; Solomon SS; Tsertsvadze T; Denkinger CM; Linas B
    J Hepatol; 2019 Jul; 71(1):62-70. PubMed ID: 30797050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence of hepatitis C virus infection among surgical nurses, their patients and blood donation candidates in Poland.
    Ganczak M; Korzeń M; Szych Z
    J Hosp Infect; 2012 Dec; 82(4):266-70. PubMed ID: 23110996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.